At a time when many big-ticket GPs are buying up specialist life science investors, France-based Jeito Capital is focused on staying an independent investor as it gears up to deploy the remaining third of its EUR 534m debut fund, founder Rafaèle Tordjman tells Unquote.
Latest co-mingled vehicle is around a third larger than previous two programmes in the series
Deal with MidEuropa sealed after auction for ophthalmology group went quiet earlier this month
Vendor Horizon collected offers for the agricultural information services provider last week
Multi-family office will doubling down on manager selectivity, opportunities in secondaries, and family offices' interest in increasing PE exposure